U.S. Bancorp | BTIG to Host Turn Therapeutics for Virtual Fireside ChatBusiness Wire · 3 days ago
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific OfficerGuruFocus · Sep 9, 2026
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D.Business Wire · Sep 9, 2026
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and ItchGuruFocus · Aug 20, 2026
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and ItchBusiness Wire · Aug 20, 2026
Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial ResultsBusiness Wire · Aug 12, 2026Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance.